Along with ten other organisations representing patients across the UK and Europe, National Voices has signed a letter warning EU negotiators of the risk of drugs getting stuck at borders, regulatory systems for medicines splintering and potential breakthrough research collaborations being forced to stall.
The letter to Brexit negotiators Michel Barnier and David Davis makes a plea to both sides of the negotiations not to forget about patients.
The signatories to the letter, who include the heads of the European Patients Forum, and National Voices' members Cancer Research UK, the British Heart Foundation, the Association of Medical Research Charities, and Genetic Alliance UK, cite the future of European clinical research as being particularly important.
For some patients, particularly those with a rare or less common disease, working together across nations is the only way that sufficient expertise and patient numbers can be brought together to progress research. It’s vital that patients across the EU can continue to take part in pioneering clinical trials.